The Effect of Integrated Prevention and Treatment on Child Malnutrition and Health in Burkina Faso: a Cluster Randomized Intervention Study (PROMIS-BF)

Globally, child undernutrition is the underlying cause for 3.1 million deaths of children younger than 5 years. 18.7 million children under five years of age suffer from severe acute malnutrition (SAM) and an additional 33 million children suffer from moderate acute malnutrition, and are at risk of developing SAM

In Sub-Saharan Africa, there is often poor integration between programs to treat child acute malnutrition and programs that focus on the prevention of acute and chronic undernutrition - resulting in many missed opportunities for using prevention platforms to screen and refer SAM children, or for using screening and referral platforms to provide prevention services.

This project will address two critical gaps related to the integration of preventive and treatment programs: 1) screening and treatment of MAM/SAM have not yet been systematically integrated into routine health-center visits or mainstreamed into community outreach programs; and 2) screening programs often do not offer any preventive services for those children found not to be suffering from MAM/SAM at the time of screening; mothers of children identified as non-MAM/SAM case are usually sent home without receiving any health or nutrition inputs and as a result, may fail to come back for screening because they do not see any tangible benefit associated with their participation in the screening. This project will specifically address these gaps by assessing the effect of an integrated approach consisting of higher screening coverage and preventive Behavior Change Communication (BCC) + Small-Quantity Lipid-based Nutrient supplementation (SQ-LNS) on both prevention and treatment of child undernutrition.

Study Overview

Detailed Description

Because of the intended dual role of BCC/SQ-LNS on child undernutrition in this study - e.g. to help prevent child undernutrition and enhance the coverage of screening, referral and treatment of SAM/MAM, it is necessary to combine two study designs to rigorously evaluate the impact of the proposed intervention and to tease out the contribution of prevention and enhanced coverage/treatment to the overall impact on child malnutrition.

The proposed study will therefore use two types of study designs. The first one is a repeated cross-sectional design that will compare select study outcomes between intervention and control groups at endline, after 24 months of program implementation. A repeated cross-sectional study design among children 0-17 months, at baseline and at study endline (on different children) will be used to assess the impact of the intervention on the prevalence of several outcomes, including the prevalence of MAM/SAM and stunting, the coverage of MAM/SAM screening and maternal ENA/IYCF/WASH knowledge and practices. The second proposed study design entails a longitudinal design whereby individual children will be recruited at birth and followed-up monthly until they reach 18 months of age. We anticipate needing approximately 5 months to recruit the required number of children (estimated at 2,040- 1,020 in the control group and 1,020 in the intervention group). This design will allow us to assess the intervention's effects on the incidence, recovery and recurrence rates of MAM/SAM.

Study Type

Interventional

Enrollment (Anticipated)

2400

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Région Du Nord
      • Gourcy, Région Du Nord, Burkina Faso
        • Gourcy Health District

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 1 year (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Cross-sectional study (baseline and endline) (n=2,310)

Inclusion Criteria:

  • At least one index child 0-17 months of age in the household
  • Mother should be living in the study area since the index child's delivery
  • Singleton infants

Exclusion Criteria:

- Index child should not present congenital deformations that hamper anthropometric measurements

Longitudinal study (n=2,180)

Inclusion Criteria:

  • child 0-1.4 months of age;
  • Mother should be living in the study area since the index child's delivery
  • Singleton infants

Exclusion Criteria:

  • Congenital malformations that make anthropometric measurements impossible
  • Mother planning to leave the study area in the coming year
  • Children of 1.5 month of age or older at study inclusion
  • WHZ<-2 both at enrollment and at the first follow-up.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PROMIS intervention
  • Small group behavior change communication (BCC) on Essential Nutrition Actions (ENA), Infant and Young Child Feeding (IYCF) and Water, sanitation and hygiene (WASH) is provided during monthly well-baby visits for children 0-17 months of age
  • Caregivers with children 0-17 months of age that attend the well-baby visit will be provided with a monthly dose of LNS (20g/day)
A monthly dose of LNS (31 sachets of 20g) will be distributed to mothers attending well-baby visits and participating in small group counseling
Other Names:
  • Lipid-based nutrient supplement (LNS)

After the well-baby visit. Caregivers will be invited to participate in a small group counseling or BCC (2-3 caregivers at a time).

Every month a set of topics related to child's health and nutrition will be treated. These BCC sessions will be organized in an interactive way centering around the condition of the participating children.

Active Comparator: control
Monthly well-baby visits as prescribed by national policy This arm is the basic comparison arm. Caregivers are invited to frequent the health center once a month for well-baby visits. During these visits necessary vaccinations are administered, child growth and nutrition status is evaluated and preventive counseling on child nutrition and health is provided in large groups of caregivers.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of acute child malnutrition defined by WHZ<-2 or MUAC <125mm or bilateral pitting edema in children 0-17 months of age
Time Frame: After 24 months of program implementation
  • Cross-sectional study
  • To calculate WHZ scores the 2006 WHO growth reference will be used
  • The MUAC criterion (125mm) is only used for children 6-17months of age
After 24 months of program implementation
Screening coverage of acute child malnutrition (proportion of children monthly screened / total number of eligible children (aged 0-17 months)
Time Frame: monthly from study inclusion at 0 months to 17 months of age and at study endline
  • Cross-sectional study
  • Longitudinal study
monthly from study inclusion at 0 months to 17 months of age and at study endline
Incidence of child acute malnutrition defined by WHZ<-2 or MUAC<125mm
Time Frame: monthly from study inclusion at 0 months to 17 months of age
  • Longitudinal study
  • To calculate WHZ scores the 2006 WHO growth reference will be used
monthly from study inclusion at 0 months to 17 months of age
Compliance to treatment of acute malnutrition (% of cases that complete treatment over total admitted)
Time Frame: monthly from study inclusion at 0 months to 17 months of age and at study endline
  • Cross-sectional study
  • Longitudinal study
monthly from study inclusion at 0 months to 17 months of age and at study endline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of child stunting defined by HAZ<-2 in children 0-17 months of age
Time Frame: After 24 months of program implementation
To calculate HAZ scores the 2006 WHO growth reference will be used
After 24 months of program implementation
Mean WHZ-score in children 0 -17 months of age
Time Frame: After 24 months of program implementation
To calculate WHZ scores the 2006 WHO growth reference will be used
After 24 months of program implementation
Mean HAZ-score in children 0-17 months of age
Time Frame: After 24 months of program implementation
To calculate HAZ scores the 2006 WHO growth reference will be used
After 24 months of program implementation
Mean mid-upper arm circumference in children 0-17 months of age
Time Frame: After 24 months of program implementation
After 24 months of program implementation
Mean hemoglobin concentration in children 3-17 months of age
Time Frame: After 24 months of program implementation
Hemocues will be used to measure Hb concentration
After 24 months of program implementation
Prevalence of child anemia (Hb concentration<10g/dL) in children 3 - 17 months of age
Time Frame: After 24 months of program implementation
After 24 months of program implementation
Prevalence of severe acute child malnutrition defined by a WHZ<-3 or bilateral pitting edema or a MUAC<115mm in children 0-17 months of age
Time Frame: After 24 months of program implementation
The MUAC criterion (115mm) is only used for children 6-17months of age
After 24 months of program implementation
Prevalence of severe stunting defined by a HAZ<-3 in children 0-17 months of age
Time Frame: After 24 months of program implementation
To calculate HAZ scores the 2006 WHO growth reference will be used
After 24 months of program implementation
Caregiver's knowledge and practices related to Infant and Young Child Feeding (IYCF), Essential Nutrition Actions (ENA) and Water, Sanitation and Hygiene (WASH)
Time Frame: After 24 months of program implementation
After 24 months of program implementation
Incidence of child stunting defined by HAZ<-2 in children from 0 to 17 months
Time Frame: monthly from inclusion at 0 months to 17 months of age
To calculate HAZ score the 2006 WHO growth reference will be used
monthly from inclusion at 0 months to 17 months of age
Linear growth velocity (HAZ increment/month)
Time Frame: monthly from inclusion at 0 months to 17 months of age
To calculate HAZ score the 2006 WHO growth reference will be used
monthly from inclusion at 0 months to 17 months of age
Ponderal growth velocity (WHZ increment/month)
Time Frame: monthly from inclusion at 0 months to 17 months of age
To calculate WHZ score the 2006 WHO growth reference will be used
monthly from inclusion at 0 months to 17 months of age
Weight gain (weight increment/month)
Time Frame: monthly from inclusion at 0 months to 17 months of age
monthly from inclusion at 0 months to 17 months of age
Mid-upper arm circumference gain (MUAC increment/month)
Time Frame: monthly from inclusion at 0 months to 17 moths of age
monthly from inclusion at 0 months to 17 moths of age
Infant morbidity (acute respiratory infections, fever, malaria (RDT), vomiting, diarrhea)
Time Frame: monthly from inclusion at 0 months to 17 moths of age
Malaria will be tested in case of fever (or recalled fever over last 24hrs) use rapid tests
monthly from inclusion at 0 months to 17 moths of age
Relapse rate after treatment of MAM/SAM (proportion WHZ<-2 or MUAC<125mm or bilateral pitting edema after discharge from MAM or SAM treatment program over total number of children treated)
Time Frame: monthly from inclusion at 0 months to 17 months of age
monthly from inclusion at 0 months to 17 months of age

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marie Ruel, PhD, International Food Policy Research Institute
  • Principal Investigator: Jean-Celestin Somda, MD, Helen Keller International

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 6, 2014

Primary Completion (Actual)

March 1, 2017

Study Completion (Actual)

May 1, 2017

Study Registration Dates

First Submitted

September 16, 2014

First Submitted That Met QC Criteria

September 17, 2014

First Posted (Estimate)

September 19, 2014

Study Record Updates

Last Update Posted (Actual)

March 9, 2018

Last Update Submitted That Met QC Criteria

March 8, 2018

Last Verified

March 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • IFPRI-2014-001
  • DFATD (Other Grant/Funding Number: 52308/5252/0200)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Child Acute Malnutrition

Clinical Trials on LNS

Subscribe